Invion Ltd. has released a press release.
Smoking cessation trial results of ongoing data analysis
Filed with ASX ·
6ix hasn’t read this filing yet.
Later from Invion
- Invion completes SPP and Placement
- Appendix 4D and Half Year Accounts
- Smoking cessation patent allowance and Operational update
- Invion announces no secondary capital raise
- End of Phase 2 Meeting for INV102 (nadolol)
Follow Invion into a list and get an email when it puts out news.
Follow Invion